Possible clinical outcome measures for clinical trials in patients with multiple sclerosis by Myla D. Goldman, Robert W. Motl, Richard A. Rudick

Get full text

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis. by Richard A Rudick, M R Sandhya Rani, Yaomin Xu, Jar-Chi Lee, Jie Na, Jennifer Shrock, Anupama Josyula, Elizabeth Fisher, Richard M Ransohoff

Get full text

Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability by Matthew R. Brier, Abraham Z. Snyder, Aaron Tanenbaum, Richard A. Rudick, Elizabeth Fisher, Stephen Jones, Joshua S. Shimony, Anne H. Cross, Tammie L. S. Benzinger, Robert T. Naismith

Get full text

Measuring treatment response to advance precision medicine for multiple sclerosis by Peter A. Calabresi, Ludwig Kappos, Gavin Giovannoni, Tatiana Plavina, Irene Koulinska, Michael R. Edwards, Bernd Kieseier, Carl deMoor, Elias S. Sotirchos, Elizabeth Fisher, Richard A. Rudick, Alfred Sandrock

Get full text

Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform by Stephen Lee, Tatiana Plavina, Carol M. Singh, Kuangnan Xiong, Xiaolei Qiu, Richard A. Rudick, Peter A. Calabresi, Lauren Stevenson, Danielle Graham, Denitza Raitcheva, Christopher Green, Madeleine Matias, Arejas J. Uzgiris

Get full text

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) by Ellen M. Mowry, Robert A. Bermel, James R. Williams, Tammie L. S. Benzinger, Carl de Moor, Elizabeth Fisher, Carrie M. Hersh, Megan H. Hyland, Izlem Izbudak, Stephen E. Jones, Bernd C. Kieseier, Hagen H. Kitzler, Lauren Krupp, Yvonne W. Lui, Xavier Montalban, Robert T. Naismith, Jacqueline A. Nicholas, Fabio Pellegrini, Alex Rovira, Maximilian Schulze, Björn Tackenberg, Mar Tintore, Madalina E. Tivarus, Tjalf Ziemssen, Richard A. Rudick

Get full text